HIGH RISK NEUROBLASTOMA
Clinical trials for HIGH RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with aggressive cancer: Two-Year treatment aims to keep disease at bay
Disease control OngoingThis study is testing whether a drug called eflornithine, taken for two years, can help children with high-risk neuroblastoma stay cancer-free after they finish their main treatments, including immunotherapy. Researchers will follow 20 children under 18 to see if this maintenance…
Matched conditions: HIGH RISK NEUROBLASTOMA
Sponsor: Shanghai Children's Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:47 UTC
-
New hope for kids with tough cancer: adding a pill to standard treatment
Disease control OngoingThis study is for children whose high-risk neuroblastoma has come back or stopped responding to initial treatment. It tests whether adding a pill called eflornithine (DFMO) to a standard combination of chemotherapy and immunotherapy works better. The goal is to see if the new com…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for kids with tough cancer: trial tests supercharged treatment
Disease control OngoingThis study is testing whether adding an immunotherapy drug called dinutuximab to standard chemotherapy works better for children newly diagnosed with high-risk neuroblastoma, a serious childhood cancer. The trial involves 42 young patients and aims to see if this combination is s…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC